Lindvi Gudmundsdotter

Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment

Anna‐Karin Roos, Fredrik Eriksson, James A. Timmons et al. · PLoS ONE · 2009 · 134 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +17

Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification

Magdalena Malm, Nina Kronqvist, Hanna Lindberg et al. · PLoS ONE · 2013 · 73 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity

Lindvi Gudmundsdotter, Charlotta Nilsson, Andreas Bråve et al. · Vaccine · 2009 · 69 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation

Andreas Bråve, Lindvi Gudmundsdotter, Eric Sandström et al. · Vaccine · 2010 · 62 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis

Susanne Klint, Joachim Feldwisch, Lindvi Gudmundsdotter et al. · mAbs · 2023 · 62 citations · Full text

Medicine, Immunology, Pharmacology +17